The Potential Role of Chemerin, Lipocalin 2, and Apelin in the Diagnosis and Pathophysiology of Gestational Diabetes Mellitus

Table 3

Correlation between chemerin, lipocalin, apelin levels, maternal age, gravidity, BMI, EFW, gestational age, and glucose concentrations in OGTT in GDM patients and control group.

	GDM						Control
	Chemerin		Lipocalin 2		Apelin		Chemerin		Lipocalin 2		Apelin
	Chemerin			0.631		0.005	NS			0.635		-0.048	NS
Lipocalin 2	0.631				-0.067	NS	0.635				-0.016	NS
Maternal age (years)	0.157	NS	0.217		-0.108	NS	0.024	NS	0.183	NS	-0.060	NS
Gravidity	0.090	NS	0.130	NS	0.040	NS	0.106	NS	0.216		0.054	NS
Pregestational BMI (kg/m^2)	0.775		0.467		-0.105	NS	0.500		0.311		0.003	NS
BMI at blood collection (kg/m^2)	0.693		0.394		-0.087	NS	0.493		0.276		0.054	NS
EFW at blood collection (g)	-0.032	NS	-0.063	NS	-0.145	NS	-0.060	NS	0.091	NS	0.055	NS
Weeks of gestation at blood collection	-0.005	NS	-0.066	NS	-0.156	NS	-0.094	NS	0.084	NS	0.005	NS
Glucose
0’	0.528		0.266		0.053	NS	0.817		0.553		0.074	NS
60’	0.731		0.425		0.011	NS	0.740		0.511		-0.122	NS
120’	0.703		0.491		-0.051	NS	0.707		0.423		-0.047	NS

GDM: gestational diabetes mellitus; BMI: body mass index; EFW: estimated fetal weight; : Spearman correlation’s coefficient; : statistical significance; NS: statistically not significant.